Cameco gives Silex-backed Paducah project a buyer for every planned product

Silex Systems Limited (ASX:SLX; OTCQX: SILXY) has found a buyer for every unit the planned Paducah Laser Enrichment Facility could eventually produce. Its 51%-owned Global Laser Enrichment (GLE) has signed an exclusive offtake agreement with Cameco Corporation, covering future natural uranium hexafluoride and enriched uranium products from the proposed Kentucky plant.

Cameco Deal Sets Commercial Framework for Paducah

The agreement gives GLE a pricing mechanism tied to Cameco’s average realised price across its annual long-term contracting portfolio, less appropriate selling costs. The announcement does not disclose the facility’s planned production volumes, the duration of the agreement, minimum purchase commitments or expected revenue.

For GLE, the arrangement also avoids the need to build its own sales and marketing operation. Silex chief executive and managing director Michael Goldsworthy said the agreement would provide a “home for all of GLE’s future nuclear fuel products” and described it as a key commercial pillar supporting a possible final investment decision for the Paducah facility (ASX:SLX).

Paducah Still Depends on Feasibility and Licensing

The offtake is not a construction order. Silex said any future FID would depend on factors including a feasibility assessment, industry and government support and market conditions. The SILEX uranium enrichment technology also remains subject to its maturation program, commercial plant licensing and the broader demand for natural and enriched uranium.

GLE is the exclusive licensee of Silex’s SILEX laser enrichment technology. Cameco holds a 49% interest in GLE and also owns 49% of Westinghouse Electric Company, giving the agreement a direct link to a major participant in the nuclear fuel industry, according to Silex.

Potential Product Range Extends Beyond Conventional Fuel

If the project clears those hurdles, Silex says the technology could produce natural-grade uranium as UF6, low-enriched uranium, LEU+ and high-assay LEU for advanced reactors, including small modular reactors. That is a description of potential applications rather than a production forecast: the company cautioned that the commercial future of the technology remains uncertain and that its deployment plans are speculative.

The next material markers are therefore practical rather than promotional: completion of the feasibility work, further technology maturation, licensing progress, financing arrangements and a formal FID. Until those steps are resolved, Cameco’s commitment gives Paducah a prospective customer and pricing framework, but not yet an operating plant or confirmed cash flow.